The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Recent data have shown that the inadequate vitamin D status plays a role in the manifestation
of the haematologic tumors and serum vitamin D level has a prognostic role also as it
determines the tumor mortality. But data have not proved a causal relationship between the
inadequate vitamin D status and the unfavourable outcomes so far. It is also still unknown,
whether the normalization of vitamin D status in patient with vitamin D inadequacy is able to
improve the prognosis and survival.
In this study the investigators examine the role of the adequate vitamin D substitution in
the improvement of the outcomes of haematologic disorders.